Fate Therapeutics Stock Forecast

Buy or Hold candidate since Jun 29, 2026 Gain 24.79%

The Fate Therapeutics stock price gained 1.00% on the last trading day (Tuesday, 7th Jul 2026), rising from $2.99 to $3.02. During the last trading day the stock fluctuated 9.00% from a day low at $2.89 to a day high of $3.15. The price has risen in 7 of the last 10 days and is up by 40.47% over the past 2 weeks. Volume fell on the last day by -974 thousand shares and in total, 2 million shares were bought and sold for approximately $7.31 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $3.08 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 74.05% during the next 3 months and, with a 90% probability hold a price between $3.52 and $5.37 at the end of this 3-month period.

FATE Signals & Forecast

The Fate Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.74 and $2.24. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Fate Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.70 and $2.37. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Fate Therapeutics finds support just below today's level at $2.70. If this is broken, then the next support from accumulated volume will be at $2.37 and $2.36.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.260 between high and low, or 9.00%. For the last week, the stock has had daily average volatility of 12.44%.

Our recommended stop-loss: $2.93 (-3.00%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (FATE) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Fate Therapeutics to open at $3.02, and during the day (based on 14 day Average True Range), to move between $2.89 and $3.15, which gives a possible trading interval of +/-$0.269 (+/-9.33%) up or down from last closing price. If Fate Therapeutics takes out the full calculated possible swing range there will be an estimated 9.33% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.70, some $0.320 (10.60%) from the current price of $3.02, our system finds the risk reward attractive.

Is Fate Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Fate Therapeutics stock to perform well in the short-term.

Current score: 3.182 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $3.02 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk